CD1C and epidermal disease: The identification of molecular fingerprints of inflammatory skin states, including the enrichment of the CD1C+CD301A+ myeloid dendritic cell population in psoriatic epidermis, provides a critical step toward elucidating epidermal diseases of development, differentiation and inflammation.